RS

Romesh R. Subramanian

DT Dyne Therapeutics: 13 patents #1 of 6Top 20%
📍 Framingham, MA: #1 of 118 inventorsTop 1%
🗺 Massachusetts: #33 of 11,797 inventorsTop 1%
Overall (2025): #3,440 of 469,880Top 1%
13
Patents 2025

Issued Patents 2025

Showing 1–13 of 13 patents

Patent #TitleCo-InventorsDate
12428487 Complexes comprising an anti-transferrin receptor antibody linked to an oligonicleotide and method of delivering oligonucleotide to a subject Mohammed T. Qatanani, Timothy Weeden, Cody A. Desjardins 2025-09-30
12403203 Muscle targeting complexes and uses thereof for treating dystrophinopathies Mohammed T. Qatanani, Timothy Weeden, Cody A. Desjardins, Brendan Quinn, John Najim 2025-09-02
12397062 Muscle targeting complexes and uses thereof for treating dystrophinopathies Mohammed T. Qatanani, Timothy Weeden, Cody A. Desjardins, Brendan Quinn, John Najim 2025-08-26
12370264 Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject Mohammed T. Qatanani, Timothy Weeden, Cody A. Desjardins 2025-07-29
12357703 Muscle-targeting complexes comprising an anti-transferin receptor antibody linked to an oligonucleotide and method of use thereof to induce exon skipping Mohammed T. Qatanani, Timothy Weeden 2025-07-15
12329824 Muscle targeting complexes and uses thereof for treating dystrophinopathies Mohammed T. Qatanani, Timothy Weeden, Cody A. Desjardins, Brendan Quinn, John Najim 2025-06-17
12329825 Muscle targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of use thereof to induce exon skipping of exon 44 of dystrophin in a subject Mohammed T. Qatanani, Timothy Weeden 2025-06-17
12325753 Method of using an anti-transferrin receptor antibody to deliver an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy Mohammed T. Qatanani, Timothy Weeden 2025-06-10
12319743 Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject Mohammed T. Qatanani, Timothy Weeden, Cody A. Desjardins 2025-06-03
12280122 Muscle targeting complexes and uses thereof for treating myotonic dystrophy Mohammed T. Qatanani, Timothy Weeden, Cody A. Desjardins 2025-04-22
12263225 Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of use thereof to target dystrophin and to treat Duchenne muscular dystrophy Mohammed T. Qatanani, Timothy Weeden 2025-04-01
12239716 Muscle targeting complexes and uses thereof for treating dystrophinopathies Mohammed T. Qatanani, Timothy Weeden, Cody A. Desjardins, Brendan Quinn, John Najim 2025-03-04
12239717 Muscle targeting complexes and uses thereof for treating dystrophinopathies Mohammed T. Qatanani, Timothy Weeden, Cody A. Desjardins, Brendan Quinn, John Najim 2025-03-04